Number of pages: 100 | Report Format: PDF | Published date: April 18, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
Report Attribute |
Details |
Market Size Value in 2022 |
US$ 486.66 million |
Market Size Value in 2031 |
US$ 698.69 million |
CAGR |
4.10% |
Base Year For Estimation |
2022 |
Forecast Period |
2023 to 2031 |
Historical Year |
2021 |
Segments Covered |
Application, End User, Distribution Channel, and Region |
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global amorphous hydrogel dressings market was valued at US$ 486.66 million in 2022 and is expected to register a revenue CAGR of 4.10% to reach US$ 698.69 million by 2031.
Amorphous Hydrogel Dressings Market Fundamentals
Amorphous hydrogel dressings are wound dressings composed of water or glycerin-based gel without any defined shape or structure. They are commonly used for managing wounds with low to moderate exudate levels, such as chronic wounds, burns, and ulcers. The amorphous hydrogel dressings are designed to keep the wound moist, promote autolytic debridement, and create a favorable environment for wound healing.
The global amorphous hydrogel dressings market has been experiencing steady growth in recent years due to various factors, such as an aging population, increasing prevalence of chronic wounds, rising awareness about advanced wound care products, and technological advancements in wound care. The growing demand for amorphous hydrogel dressings in home healthcare settings and the increasing adoption of advanced wound care products in developing countries drive market revenue growth. The market for amorphous hydrogel dressings is highly competitive, with several established players and new entrants vying for market share. These companies offer a wide range of amorphous hydrogel dressings with different features, such as antimicrobial properties, transparency, and ease of application. Key players in the amorphous hydrogel dressings market include Smith & Nephew plc, 3M Company, ConvaTec Group plc, Coloplast A/S, Mölnlycke Health Care AB, Medline Industries, Inc., Hollister Incorporated, B. Braun Melsungen AG, DermaRite Industries LLC, and Advancis Medical.
[6866]
Amorphous Hydrogel Dressings Market Dynamics
The demand for amorphous hydrogel dressings has steadily increased due to their effectiveness in wound management. Amorphous hydrogel dressings are used for various acute and chronic wounds, burns, and surgical wounds. The rising occurrence of chronic wounds such as diabetic foot ulcers and pressure ulcers has driven the demand for amorphous hydrogel dressings. The demand for hydrogel dressings is predicted to rise due to an increase in the number of burn victims worldwide. In a February 2021 article, the American Burn Association stated that more than 400,000 People receive treatment for burn injuries yearly. The WHO estimates that 6.6 million people worldwide suffer from yearly heat burn. As a result, the global market for amorphous hydrogel dressings is expected to increase rapidly during the forecast period. Age-related chronic wounds, such as venous leg ulcers and pressure ulcers, necessitate advanced wound care therapy. Amorphous hydrogel dressings successfully treat wounds in older patients. Thus, demand for them is predicted to rise as the world’s population ages. Advanced amorphous hydrogel dressings with improved qualities, such as antibacterial activities, increased wear life, and improved moisture management, are being developed by manufacturers emphasizing continual innovation. These developments are intended to improve patient outcomes and broaden the use of amorphous hydrogel dressings in the wound care industry. With the rising healthcare costs, there is a growing focus on cost-effective wound care solutions. Amorphous hydrogel dressings are considered cost-effective compared to other advanced wound care products, such as foam dressings or negative pressure wound therapy (NPWT). This has led to increased adoption of amorphous hydrogel dressings in various healthcare settings, including hospitals, clinics, and home care.
However, many factors are restraining the revenue growth of the global amorphous hydrogel dressings market. The availability of amorphous hydrogel dressings may vary depending on the region or country. Some regions or markets may need more access to amorphous hydrogel dressings due to regulatory restrictions, distribution challenges, or lack of awareness. Limited availability may hinder the adoption of amorphous hydrogel dressings, particularly in underserved or remote areas. Although amorphous hydrogel dressings have been used in wound care for many years and have shown effectiveness in managing certain types of wounds, there may be a need for robust clinical evidence supporting their efficacy compared to other wound dressings. This may create uncertainty among healthcare providers and impact the adoption of amorphous hydrogel dressings in clinical practice.
Amorphous Hydrogel Dressings Market Ecosystem
The global amorphous hydrogel dressings market is analyzed from four perspectives: application, end user, distribution channel, and region.
Amorphous Hydrogel Dressings Market by Application
[86766]
Based on application, the global amorphous hydrogel dressings market is segmented into burns, surgical wounds, pressure ulcers, and others.
The pressure ulcer segment accounts for the largest revenue share in the global amorphous hydrogel dressings market. Pressure ulcers, also known as bedsores or pressure sores, are localized areas of skin and underlying tissue damage that occurs when there is prolonged pressure or friction on the skin. These ulcers often develop in individuals who are immobile or have limited mobility, such as those who are bedridden, use a wheelchair, or have other medical conditions that restrict movement. Patients suffering from spinal cord injury and strokes are most likely to suffer from pressure ulcers. Kendall™ amorphous hydrogel wound dressing manufactured by Cardinal Health is formulated to manage Stage II-IV pressure ulcers.
Amorphous Hydrogel Dressings Market by End User
Based on end users, the global amorphous hydrogel dressings market is segmented into hospitals, ambulatory surgical centers, and others.
The hospital’s segment accounted for the largest global amorphous hydrogel dressings market revenue share. The prevalence of bariatric procedures, which need hydrogel dressing solutions to avoid surgical site infections, and the global increase in surgical procedures because of sedentary lifestyles are the key causes of this market’s domination. Amorphous hydrogel dressings can treat these wounds because major organ donation or skin transplant surgeries occur in hospitals. They may lessen discomfort, keep the donor or graft site wet, and aid in the healing process. Many hospital patients who spend their days in bed acquire pressure or bed sores. Amorphous hydrogel dressings are also used to manage pressure ulcers or bedsores. They can help maintain a moist environment around the wound, reduce friction and shear forces, and promote healing.
The homecare settings segment is expected to record a high revenue CAGR during the forecast period. Patients’ shifting preferences towards home care settings from hospitals are responsible for this. Most operations have a prolonged healing period that requires frequent dressings changes. Elderly patients with wounds prefer home care to hospitalization. Patients with chronic conditions are choosing to receive medical care at home in greater numbers because of growing healthcare expenditures. Because hydrogel dressings are used to treat, diagnose, and monitor a range of chronic and acute wounds, this trend is anticipated to increase demand for them. As a result, these variables are expected to hasten the segment’s revenue growth during the forecast period.
Amorphous hydrogel dressings Market by Distribution Channel
Based on the end user, the global amorphous hydrogel dressings market is segmented into retail pharmacies, online pharmacies, and others.
Retail pharmacies accounted for a significant revenue share in the global amorphous hydrogel dressings market. This is because of the easier availability of comparatively pocket-friendly medications. In contrast, the online pharmacies segment is expected to record a high revenue CAGR during the forecast period. This is because of the inclination of customers towards e-commerce and increased internet penetration.
Amorphous hydrogel dressings Market by Region
Based on region, the global amorphous hydrogel dressings market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounts for a significant share of the global amorphous hydrogel dressings market. This is due to advanced healthcare infrastructure, a growing geriatric population, and increasing cases of chronic wounds, such as diabetic foot ulcers. The rising prevalence of diabetes and obesity in North America has also contributed to the demand for advanced wound care products, including amorphous hydrogel dressings. These conditions are associated with an increased risk of developing chronic wounds. Moreover, increasing awareness among healthcare providers and patients about the benefits of amorphous hydrogel dressings, such as ease of application, effectiveness in maintaining a moist wound environment, and pain relief, has also driven the demand for these products in the North American market.
Asia Pacific region is expected to record a high revenue CAGR during the forecast period. Factors such as the increasing prevalence of chronic diseases, rising geriatric population, growing awareness about advanced wound care products, and improving healthcare infrastructure in emerging economies drive the demand for amorphous hydrogel dressings in the region. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are becoming increasingly prevalent in Asia Pacific due to the growing burden of chronic diseases, such as diabetes and obesity. Amorphous hydrogel dressings effectively manage chronic wounds by providing a moist environment that promotes healing. There is a growing awareness among healthcare professionals and patients about the benefits of advanced wound care products, including amorphous hydrogel dressings. These dressings are considered innovative and effective in managing wounds, driving their adoption in Asia. Many countries in the Asia Pacific are investing in improving their healthcare infrastructure, including wound care facilities. This enables better access to advanced wound care products for regional patients, such as amorphous hydrogel dressings.
Amorphous hydrogel dressings Market Competitive Landscape
The prominent players operating in the global amorphous hydrogel dressings market are:
Amorphous Hydrogel Dressings Market Strategic Developments
The expected size of the global amorphous hydrogel dressings market in 2031 is US$ 698.69 million.
The expected revenue CAGR for the amorphous hydrogel dressings market is 4.1% during the forecast period.
Smith & Nephew plc, DermaRite Industries LLC, 3M Company, Cardinal Health, ConvaTec Group plc, and B. Braun Melsungen AG are key players operating in the amorphous hydrogel dressings market.
The Asia Pacific region is expected to grow at high revenue CAGR in the global amorphous hydrogel dressings market.
The wound care market is highly competitive, with various types of wound dressings available, such as foams, films, and alginate dressings. Amorphous hydrogel dressings may face competition from these other types of dressings and newer wound care technologies and products. This competition may limit amorphous hydrogel dressings’ market revenue share and growth potential.
*Insights on financial performance are subject to the availability of information in the public domain